Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13250-13263
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13250
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13250
Table 3 Multivariate analysis of different factors associated with disease-free survival in hepatocellular carcinoma patients
Characteristics | HR value (95%CI) | P value |
Age (yr) | ||
< 70 | 1.00 (reference) | |
≥ 70 | 0.543 (0.328, 0.898) | 0.017a |
History of hepatitis B | ||
Yes | 1.00 (reference) | |
No | 0.654 (0.472, 0.907) | 0.011a |
Hypertension | ||
Yes | 1.00 (reference) | |
No | 0.754 (0.510, 1.114) | 0.156 |
Cancer nodules (Single/ Multiple) | ||
Single | 1.00 (reference) | |
Multiple | 1.009 (0.579, 1.757) | 0.975 |
Tumor diameter (cm) | ||
< 5 | 1.00 (reference) | |
≥ 5 | 1.125 (0.817, 1.548) | 0.471 |
TNM stage | ||
III-IV | 1.00 (reference) | |
I-II | 0.585 (0.423, 0.810) | 0.001a |
Portal vein thrombus | ||
No | 1.00 (reference) | |
Yes | 1.784 (0.885, 3.597) | 0.106 |
Fibrinogen (> 4 g/L/≤ 4 g/L) | ||
≤ 4 g/L | 1.00 (reference) | |
> 4 g/L | 1.304 (0.872, 1.951) | 0.196 |
- Citation: Luo PQ, Ye ZH, Zhang LX, Song ED, Wei ZJ, Xu AM, Lu Z. Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model. World J Clin Cases 2022; 10(36): 13250-13263
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13250.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13250